Gabe C, Ziza K, Durazzo N, Pagani F, Oliveira V, Conrado M
Hematol Transfus Cell Ther. 2022; 45 Suppl 2:S101-S107.
PMID: 36114116
PMC: 10433308.
DOI: 10.1016/j.htct.2022.06.005.
Mathews N, Rivard G, Bonnefoy A
J Blood Med. 2021; 12:449-463.
PMID: 34149292
PMC: 8205616.
DOI: 10.2147/JBM.S271744.
Hassan M, Sharmin S, Kim H, Hong S
Circ Res. 2020; 128(3):386-400.
PMID: 33292062
PMC: 7861503.
DOI: 10.1161/CIRCRESAHA.120.317245.
Owaidah T, Saleh M, Baz B, Abdulaziz B, Alzahrani H, Tarawah A
NPJ Genom Med. 2019; 4:4.
PMID: 30792900
PMC: 6375963.
DOI: 10.1038/s41525-019-0079-6.
Ogawa Y, Kunishima S, Yanagisawa K, Osaki Y, Uchiyama Y, Matsumoto N
Int J Hematol. 2016; 105(2):221-225.
PMID: 27696190
DOI: 10.1007/s12185-016-2096-x.
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G, Zotz R, dOiron R, Bindslev N, Di Minno M, Poon M
Haematologica. 2015; 100(8):1031-7.
PMID: 26001793
PMC: 5004418.
DOI: 10.3324/haematol.2014.121475.
Characterization of the cDNA and genomic DNA sequence encoding for the platelet integrin alpha IIB and beta III in a horse with Glanzmann thrombasthenia.
Macieira S, Lussier J, Bedard C
Can J Vet Res. 2012; 75(3):222-7.
PMID: 22210999
PMC: 3122970.
Extracellular matrix proteins in hemostasis and thrombosis.
Bergmeier W, Hynes R
Cold Spring Harb Perspect Biol. 2011; 4(2).
PMID: 21937733
PMC: 3281566.
DOI: 10.1101/cshperspect.a005132.
Colonoscopy polypectomy management in Glanzmann's thrombasthenia.
Raina D, Movva A, Rahhal F, Abderrahim K, Schade R, Chamberlain S
World J Gastrointest Endosc. 2010; 1(1):72-5.
PMID: 21160656
PMC: 2998848.
DOI: 10.4253/wjge.v1.i1.72.
Glanzmann's thrombasthenia: report of a case and review of the literature.
Sebastiano C, Bromberg M, Breen K, Hurford M
Int J Clin Exp Pathol. 2010; 3(4):443-7.
PMID: 20490335
PMC: 2872751.
The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.
Franchini M
Blood Transfus. 2009; 7(1):24-8.
PMID: 19290076
PMC: 2652232.
DOI: 10.2450/2008.0015-08.
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
Poon M
Vasc Health Risk Manag. 2007; 3(5):655-64.
PMID: 18078017
PMC: 2291310.
Proteomic approaches to dissect platelet function: Half the story.
Gnatenko D, Perrotta P, Bahou W
Blood. 2006; 108(13):3983-91.
PMID: 16926286
PMC: 1895451.
DOI: 10.1182/blood-2006-06-026518.
